Information Provided By:
Fly News Breaks for July 22, 2016
VIAB, SHW, UNH, EXC, CI
Jul 22, 2016 | 10:21 EDT
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Cigna (CI) upgraded to Conviction Buy from Buy at Goldman with analyst Matthew Borsch saying saying shares are undervalued and sees upside potential in capital redeployment capacity. 2. Exelon (EXC) upgraded to Buy from Hold at Deutsche Bank with analyst Jonathan Arnold saying the company is a "cheap play on regulated assets with catalysts." 3. UnitedHealth (UNH) upgraded to Buy from Hold at Argus with the firm saying it thinks that the company's decision to exit the Affordable Care Act exchanges next year will boost its Earnings Per Share in 2017, and it thinks that the outlook for the company's Optum businesses is "favorable." 4. Sherwin-Williams (SHW) upgraded to Buy from Outperform at CLSA with analyst Nils-Bertil Wallin citing valuation and sustainable long-term growth. 5. Viacom (VIAB) upgraded to Neutral from Underweight at Atlantic Equities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
News For CI;EXC;UNH;SHW;VIAB From the Last 2 Days
UNH
Mar 28, 2024 | 15:22 EDT
What has Wall Street been buzzing about this week? Here are the top 5 Bu-y calls and the top 5 Sell calls made by Wall Street’s best analysts during the week of March 25-28. Find all top-rated... To see the rest of the story go to thefly.com. See Story Here
UNH
Mar 28, 2024 | 06:51 EDT
BofA downgraded Molina Healthcare (MOH) to Underperform from Neutral with a $439 price target. The firm, which is concerned that Molina and the Medicaid industry more broadly are likely to face rate pressure after a period of elevated margins, sees a less attractive risk/reward for Molina compared to other insurers the firm covers, the analyst tells investors. Molina is now trading roughly at parity with the firm's top pick in the space, UnitedHealth (UNH), compared to a 22% discount that had been seen over the last five years, helping to underscore the firm's view that "sentiment for Medicaid is nearing a top just at a time when Medicare is reaching a bottom," the analyst added.